Luetkemeyer, A. F., McDonald, C., Ramgopal, M., Noviello, S., Bhore, R., & Ackerman, P. (2016). 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Clin Infect Dis.
シカゴスタイル引用形Luetkemeyer, Anne F., Cheryl McDonald, Moti Ramgopal, Stephanie Noviello, Rafia Bhore, , Peter Ackerman. "12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety By HIV Combination Antiretroviral Regimens." Clin Infect Dis 2016.
MLA引用形式Luetkemeyer, Anne F., et al. "12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety By HIV Combination Antiretroviral Regimens." Clin Infect Dis 2016.